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In this study a miniaturized LC coupled to electrospray tandem mass spectrometry was used
to analyze modifications originating from the interaction between the chemotherapeutic agent
melphalan and 2-oligodeoxynucleotides. Low energy CAD product ion spectra gave infor-
mation about the specificity of melphalan alkylation with regard to certain DNA sequences.
These data can be very useful to estimate the risk in the development of secondary leukaemia
as a result of a melphalan cure. In the study of the interaction between melphalan and d(GG),
differentiation could be made between alkylation on the 5-side and alkylation on the 3-side,
because of the presence or absence of the alkylated w1 fragment in the low energy CAD
spectra. In the other di-mers alkylation specificity for the different bases could be observed.
Melphalan alkylation occurs in the sequence G  A  C  T. The study of the alkylated
d(GGGG) revealed the presence of mainly 5-end alkylation. Furthermore studies were
performed which investigated other melphalan treated di-, tetra-, hepta-, and
octa-mers. (J Am Soc Mass Spectrom 2004, 15, 568–579) © 2004 American Society for Mass
SpectrometryDNA is a target for many xenobiotica and endog-enous compounds. Electrophiles from eithersource can interact covalently with DNA with
the formation of so called DNA adducts [1]. These
adducts are believed to be the cause for an increased
risk of cancer. One of these alkylating agents is the
nitrogen mustard melphalan currently used as a che-
motherapeutic agent in the treatment of malignant
melanoma, multiple myeloma, lymphomas and ovarian
carcinoma [2]. DNA adduct formation in perfectly
healthy cells at the stage of primary cancer treatment
might explain the development of a secondary leukae-
mia afterwards. It is a well known fact throughout
literature that melphalan mainly alkylates the N-7 po-
sition in a guanine residue [3]. To the best of our
knowledge, no information is available on the regios-
electivity of melphalan alkylation in 2-oligode-
oxynucleotides and/or whole DNA strands. Therefore
there were some important issues left as there are the
degree of alkylation of G in relation to its position in the
sequence, the influence of the neighbors on the degree
of alkylation and the fragmentation patterns observed
in melphalan modified 2-oligodeoxynucleotides. Fur-
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what is the relation with earlier performed experi-
ments on individual 2-deoxynucleotides and -nucleo-
sides [4, 5].
Electrospray mass spectrometry has become a viable
technique for determining both the sequence specificity
and the chemical structure of DNA modifications. By
using this technology a lot of information was gathered
on the adduct formation between potential carcinogens
and individual 2-deoxynucleotides (dNMPs) and
-nucleosides (dNs). Furthermore modifications in
whole DNA strands are studied after enzymatic diges-
tion also resulting in the study of modified dNMPs and
dNs [6]. However, this enzymatic digestion eliminates
information related to the location of the adduct in
the DNA sequence. In this paper we wish to describe
a study of the melphalan modifications found in
2-oligodeoxynucleotides (dODNs). Modified dODNs
of 2 up to 8 bases in length were studied with the aid
of miniaturized liquid chromatography coupled to
electrospray tandem mass spectrometry (LC ES-MS/
MS).
Next to the mass spectral investigation of intact
oligodeoxynucleotides, sometimes a time-dependent
exonuclease digestion can be used as an alternative or
complementary technique to sequence oligode-
oxynucleotides and hence to determine the position of
the modification in larger ODNs [7]. In the latterr Inc. Received October 23, 2003
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moves single nucleotides from the 3- or 5-terminus,
creating a mixture of ODNs that can be rapidly detected
by MALDI-MS [8] or ES-MS [9]. In some cases enzy-
matic digestion is inhibited at the modification site
which prevents full sequence information.
After the striking demonstration that polyanionic
oligodeoxynucleotides could be transferred to the gas
phase by electrospray ionization [10], mass spectro-
metry became an attractive approach for sequencing
oligodeoxynucleotides. High quality electrospray
spectra of oligodeoxynucleotides were recorded by
Potier et al. [11], who demonstrated the use of
electrospray in this field. Under ES MS/MS condi-
tions, principal fragmentation pathways were elabo-
rated by McLuckey et al. [12], Wan et al. [13, 14] and
Wang et al. [15–17]. However, a clear distinction
Figure 1. (a) Structure of melphalan; (b) the N-
alkylation sites in dODNs.should be made between confirmation and de novo
determination of a sequence [18]. Depending on
oligodeoxynucleotide size, sample quantity and other
factors, the various proposed methods differ some-
what in their capabilities for sequencing applications.
To overcome the problem of sequencing larger oli-
godeoxynucleotides, one can use the “nearest neigh-
bor” technique as described by Rozenski and McClo-
skey [19]. The identification of nearest neighbor
residues in nucleic acids provides useful constraints
on establishment of base composition and sequence
and is potentially applicable to a range of structural
problems involving synthetic and natural polynucle-
otides. Precursor-product relationships derived from
small fragment ions produced in the high pressure
ionization region of the instrument are measured.
Measured mass values of dinucleotide- or other frag-
uanine as a potential alkylation site; (c) Possible7 of g
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formed in the collision cell and transmitted by the
second mass analyzer, establish the identities of
residues adjacent to this mononucleotide ion. These
fragment ions directly indicate the nearest neighbors
of any selected nucleotide whether or not it is mod-
ified.
In this paper we focus on the preferential modifica-
tion sites of the chemotherapeutic agent melphalan
(Figure 1) in short 2-oligodeoxynucleotides with differ-
ent sequences. Chromatography based on a method
described by Apffel et al. [20, 21] was performed on the
reaction mixtures before mass spectrometric analysis. A
good HPLC separation and efficient electrospray ion-
ization were obtained by using mobile phases contain-
ing of 1,1,1,3,3,3-hexafluoro-2-propanol (HFiP) as addi-
tive, adjusted to pH 7 with triethylamine (TEA). During
the separation, TEA formed ion pairs with the nega-
tively charged phosphate groups of the oligode-
oxynucleotide backbone. However, as the column efflu-
ent was electrosprayed and desolvated, the volatile
HFiP was depleted at the droplet surface and the pH at
Figure 2. Chromatographic separation of a m
column (C18, 300 m i.d., 5 cm length): d(
d(GTTTTTT), and d(CGTGAGCG). Mobile phase
mM HFiP in MeOH (pH 7); gradient elution wa
Figure 3. Oligonucleotide fragmentation nome
1991, 63, 18, 1971–1978).the surface rised towards 10. At these higher pH value,
the oligodeoxynucleotide-TEA ion pairs dissociated
and the oligodeoxynucleotides were desorbed into the
gas phase [20, 21].
Experimental
Materials
Water and methanol were purchased from Acros (Geel,
Belgium). Melphalan, triethylamine, and 1,1,1,3,3,3-
hexafluoro-2-propanol were obtained from Sigma-
Aldrich (Bornem, Belgium). The 2-oligodeoxynucleotides
were made to measure and desalted by Sigma-Genosys
(Cambridgeshire, UK). All samples and mobile phases
were filtered over a 0.2 m nylon syringe filter from
Alltech (Lokeren, Belgium) just before analysis. The
drug used in this study, melphalan, is listed as a
carcinogen to humans. Appropriate precautions are
necessary when handling this drug.
e of 2-ODNs on a reversed phase analytical
d(GC), d(GT), d(GA), d(GGGG), d(AGCT),
sisted of A: 400 mM HFiP in H2O (pH 7); B: 400
formed.
ure according to McLuckey et al. (Anal. Chem.ixtur
GG),
s con
s pernclat
571J Am Soc Mass Spectrom 2004, 15, 568–579 LC-ES MS/MS OF 2-OLIGODEOXYNUCLEOTIDESTable 1. Low energy CAD product ions of the unmodified 2-ODN’s. Low energy CAD spectra were obtained using a collision
energy between 20 and 40 eV. The w-fragmentation series is the most abundant one and seem to be the most reproducible one to
characterize the eventual modified 2-ODNs
[MH] n
Charge
state anBn wn yn dn
dn-
H2O
[M-
Gua]
[M-
Ade]
[M-
Cyt]
[M-
Thym]
[Gua-
H]
[Ade-
H]
[Cyt-
H]
[Thym-
H]
d(TTTGTTT) 2092 1 1 321 321 303 150 125
2 1 401 625 545 625 607
2 312
3 1 705 929 849 929 911
2 464
4 1 1009 1179
2 504 629 589 620
5 1
2 669 781 741 772
6 1
2 821 893
d(TTTTTG) 2092 1 1 346 321 303 150 125
2 1 401 650 570 625 607
2 325
3 1 705 954 874 929 911
2 477
4 1 1009 1179
2 504 629 589 607
5 1
2 656 781 741 759
6 1
2 808 893
d(ATTTTTT) 2075 1 1 321 330 312 134 125
2 1 410 625 545 616
2 312
3 1 714 929 849
2 464
4 1 1018 1234 1154
2 509 616 576
5 1
2 661 768 728
6 1
2 880
d(TTTATTT) 2075 1 1 321 303 134 125
2 1 401 625 545 607
2 312
3 1 705 929 849 911
2 464
4 1 1009 1163
2 504 621 581
5 1
2 661 773 733 764
6 1
2 813 885
d(CGTGAGCG) 2450 1 1 346 288 150 134 110 125
2 1 386 635 555 617
3 1 715 964 884 921
4 1 1019 1198
2 638
5 1
2 674
6 1
2 830
7 1
d(GG) 595 1 1 346 346 444 150
d(GA) 579 1 1 330 346 428 444 150 134
d(GC) 555 1 1 306 346 404 444 150 110
d(GT) 570 1 1 321 346 419 444 150 125
d(GGGG) 1254 1 1 346 346 328 150
2 1 426 675 595 657
3 1 755 1004 924
(continued)
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Interaction of 2-Oligodeoxynucleotides with
Melphalan
The 2-oligodeoxynucleotides were dissolved in water
to a final concentration of 1 mg/ml. A melphalan stock
solution of 1 mg/ml in water was made just before
reaction. A 2-ODN solution (100 l) was reacted with
100 l of the melphalan stock solution. As a conse-
quence, the final concentration of the start components
Table 1. (continued)
[MH] n
Charge
state anBn wn yn dn
d(GCGC) 1174 1 1 306 328
2 1 426 635 555
3 1 715 924 844
d(GACT) 1173 1 1 321
2 1 426 610 530 641
3 1 739 923 843
2 461
d(CGAT) 1173 1 1 321
2 1 386 634 554 617
3 1 715 963 883
2 481
d(TACG) 1173 1 1 346
2 1 401 635 555
2 317
3 1 714 948 868
2 473
d(TAGC) 1173 1 1 306
2 1 401 635 555
3 1 714 948 868
2 473
d(AGCT) 1173 1 1 321
2 1 410 610 530 659
2 305
3 1 739 939 859
2 469
d(GTTTTTT) 2092 1 1 321 346
2 1 426 625 545
2 312
3 1 730 929 849
2 464
3
4 1 1034 1154
2 516 616 576
3 410
5 1
2 768 728
6 1
2 880
d(TGTTTTT) 2092 1 1 321 321
2 1 401 625 545 650
2 312
3 1 730 929 849 954
2 464
4 1 1034 1234 1154
2 616 576
5 1
2 669 768 728
6 1
2 821 893in this reaction mixture was 0.5 mg/ml. The reaction
mixtures were kept at a temperature of 37 °C for a
period of 1 h. From these reaction mixtures 1 l was
directly injected on the analytical column for analysis.
Mass Spectrometric Conditions
Electrospray () mass spectra were recorded on a
Q-TOF 2 instrument (Micromass, Manchester, UK). The
mass spectrometer was equipped with a pneumatically
[M-
Gua]
[M-
Ade]
[M-
Cyt]
[M-
Thym]
[Gua-
H]
[Ade-
H]
[Cyt-
H]
[Thym-
H]
150 110
1046 150 134 125
1037 1046 150 134 110 125
1021 1037 1046 150 134 110 125
1021 1037 1046 150 134 125
1037 1046 150 134 110 125
150 125
150 125dn-
H2O
617
288
303
641
632
303
632
936
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ated with a capillary LC system (CapLC, Waters, Mill-
ford, UK). A six-way injection valve was used to load
the analytical column. The CapLC system was con-
nected to a FAMOS micro-injection system and the
standard electrospray probe was used. The voltage on
the stainless steel electrospray capillary was set at 3.5
kV. Low energy collision activated dissociation spectra
were recorded using argon as collision gas (gas cell
pressure 3.6  103 mbar). The source temperature was
kept at 120 °C. The flow rate of the nebulizing gas (N2)
Table 2. Characteristic low energy CAD product ions of the
melphanlan modified 2-ODNs as described in the text. The
product ions were used to identify the alkylation site. Low
energy CAD spectra were obtained using a collision energy
between 20 and 40 eV
2-d(ODN)
Observed
characteristic
product ion m/z
d(AGCT) [w2  mel]- 878
d(GCGC) [d1  H2O  mel]- 597
d(GGGG) [a2  B2  mel]- 695
d(GTTTTTT) [d1  mel]- 615
[d2  mel]- 919
d(TTTTTTG) [w1  mel]- 615
[w2  mel]- 919
Base
Depurination
products
G [Gua  mel]- 418
A [Ade  mel]- 402
C [Cyt  mel]- 378
Figure 4. Chromatographic separation of the m
on a reversed phase analytical column (C18, 300
400 mM HFiP in H2O (pH 7); B: 400 mM HFiP in
phase were 98% A, 2% B. These were maintai
reaching 20% A, 80% B in 18 min. These conditio
which represents alkylation on each of the presand the drying gas (N2) was 30 and 280 l/h, respec-
tively. Low energy CAD spectra were recorded using a
variable collision energy of 20 to 40 eV. Scan time was
set at 1 s, with an interscan delay of 0.1 s when a mass
range of m/z 100 to 1000 was scanned. When a mass
range of m/z 100 to 2500 was scanned, the scan time was
set at 1.5 s with an interscan delay of 0.1 s. Wherever
low energy CAD data are mentioned in the text, these
are the combined results from the fragmentation of the
[M  H], the [M  2H]2 and the [M  3H]3. This
was dependent on the size of the observed molecule.
The smaller di-mers only showed a [M  H] in very
good abundance while the octa-mers were mainly triply
ionized.
Chromatographic Conditions
The reversed phase analytical column (C18, 300 m i.d.,
5 cm length) was purchased from LC-Packings (Amster-
dam, The Netherlands). 1 L of the filtered reaction
mixture was injected on the analytical column and
eluted with gradient elution. The mobile phase con-
sisted of 400 mM HFiP, adjusted with TEA to a pH of 7.
Therefore, a stock solution of 800 mM HFiP was pre-
pared and adjusted to a pH of 7. For mobile phase A the
stock solution was diluted with water to a final concen-
tration of 400 mM HFiP. To prepare mobile phase B, the
stock solution was diluted with methanol likewise to a
final concentration of 400 mM HFiP. The starting con-
ditions of the mobile phase were 98% A, 2% B. These
were maintained for 2 min. Then a linear gradient was
started reaching 20% A, 80% B in 18 min. These condi-
lan alkylated di-mers d(GC), d(GG), and d(GA)
.d., 5 cm length). Mobile phases consisted of A:
H (pH 7). The starting conditions of the mobile
for 2 min. Then a linear gradient was started
ere maintained for 10 min. Isomers can be seen
ucleobases.elpha
m i
MeO
ned
ns w
ent n
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ical column was equilibrated with the starting condi-
tions before a next experiment was performed. The flow
rate over the analytical column was 8 L/min.
Detection Limit of 2-Oligodeoxynucleotides
The detection limit was determined by injection of 1 L
of standard diluted 2-oligodeoxynucleotides (dGG,
dGGGG, and dGTTTTTT) onto the developed miniatur-
ized LC-MS system. The high content of HFiP and TEA
had an influence on the detection limit of the com-
pounds. However we aimed at a balance between
detection limit and chromatographic performance. Us-
Figure 5. Trace A: Chromatographic separatio
tetra-mer d(AGCT) on a reversed phase analyt
phases consisted of A: 400 mM HFiP in H2O (pH
conditions of the mobile phase were 98% A, 2%
gradient was started reaching 20% A, 80% B in 1
Isomers can be seen which represents alkylation
guanine residue (Trace C). Alkylation on the thing the system as described modified or unmodified
2-oligodeoxynucleotides could be detected with a LOD
of 5  1010 g.
Results
Chromatographic Separation of
2-Oligodeoxynucleotides
As already shown by Apffel et al. [20, 21], the described
LC technique in combination with ES-MS suppresses
effective cation adduct formation and result in high
resolution separations of relatively short oligode-
oxynucleotides. As shown in Figure 2 separations were
the reaction mixture of a melphalan alkylated
olumn (C18, 300 m i.d., 5 cm length). Mobile
B: 400 mM HFiP in MeOH (pH 7). The starting
hese were maintained for 2 min. Then a linear
. These conditions were maintained for 10 min.
he adenine- (Trace D), cytosine- (Trace C), and
e base could not be observed.n of
ical c
7);
B. T
8 min
on t
ymin
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with different sequences as well as in mixtures of
oligodeoxynucleotides differing in length. The four
different di-mers were separated in a limited time
window. Their retention times tr were d(GG): 1.90 min;
d(GC): 2.18 min; d(GT): 2.47 min, and d(GA): 2.65 min.
Mixtures of oligodeoxynucleotides with different
lengths were more easily separated as can be seen on
the chromatogram given in Figure 2. The 4-mer
d(GGGG) has a tr of 9.27 min, while another 4-mer
d(AGCT) has a tr of 10.59 min. The 7-mer
d(GTTTTTT) has a tr of 14.77 min. The 8-mer d(CGT-
GAGCG) was eluting with a retention time of 16.40
min.
Figure 6. Trace A: Chromatographic separation of the reaction
mixture of a melphalan alkylated tetra-mer d(GCGC) on a re-
versed phase analytical column (C18, 300 m i.d., 5 cm length).
Mobile phases consisted of A: 400 mM HFiP in H2O (pH 7); B: 400
mM HFiP in MeOH (pH 7). The starting conditions of the mobile
phase were 98% A, 2% B. These were maintained for 2 min. Then
a linear gradient was started reaching 20% A, 80% B in 18 min.
These conditions were maintained for 10 min. Isomers can be seen
which represents alkylation on the 5-G- (Trace C) and 3-G-
residue (Trace B).Sequencing of 2-Oligodeoxynucleotides
Performing low energy CAD spectra showed typical
wn, yn, dn-H2O, and an-Bn fragments. The oligode-
oxynucleotide fragmentation nomenclature (see also
reference [22]) as depicted in Figure 3 was used, accord-
ing to the nomenclature used in the original papers of
McLuckey et al. [23]. This figure shows the major
fragmentations that occur upon collision activation.
Internal fragments are also a common feature in these
product ion spectra. The various cleavages around the
phosphodiester backbone are already described by
McLuckey et al. [12]. Procedures for interpretation of
CID mass spectra of oligodeoxynucleotides were devel-
oped explicitly for applications in which the entire
sequence is a priori unknown. In the examples de-
scribed in this manuscript the sequence was known and
this somewhat eases the problem. Nevertheless the
fragmentation data from the unmodified 2-oligode-
oxynucleotides were used to interpret the data from the
melphalan treated oligodeoxynucleotides. All oligode-
oxynucleotides had a free hydroxyl group at the 3- and
5-termini. Most straightforward were the results ob-
served for the 2-mers. Typical fragments could be
explained by the loss of the base moiety, w-fragments,
y-fragments, a-B-fragments, and d-fragments. In Table
1 the results were summarized for all compounds
studied: The 2-mers, the 4-mers, the 7-mers, and the
8-mers. This table helps the reader to interpret the
product ion spectra from the unmodified 2-ODNs as
well as from the modified 2-ODNs. The major frag-
mentation series were the w-series, which were repro-
ducible enough to sequence unknown 2-ODNs or to
determine the modification site in modified 2-ODNs.
Table 2 shows the typical product ions of some melpha-
lan modified dODNs. These ions were used to identify
the alkylation position as mentioned in the respective
paragraphs when the topic is described.
Melphalan Alkylation of Dinucleotides
In previous studies we already showed a preferred
melphalan alkylation of the guanine base in 2-
deoxynucleosides, 2-deoxynucleotides, and calf thy-
mus DNA [4, 5]. Next to this alkylation was observed at
the adenine- and the cytosine moiety. However, due to
its low nucleophilicity, thymidine alkylation could
hardly be detected. By choosing a specific oligode-
oxynucleotide sequence, the difference in alkylation
specificity could be observed. Interpreting the ES-MS
and ES-MS/MS data of alkylated d(GG), d(GA), d(GC),
and d(GT) one could notice that 2 isomers were formed
in d(GG), d(GA) and d(GC). One isomer was the result
of alkylation of the guanine moiety, while the other
isomer represented alkylation of the other base. As can
be seen in Figure 4, in the case of d(GG) a 11:14
alkylation ratio (Isomer 1/Isomer 2; [M  H]  863)
could be calculated by comparing the peak areas of the
corresponding chromatographic signals. The product
576 VAN DEN DRIESSCHE ET AL. J Am Soc Mass Spectrom 2004, 15, 568–579ion spectra showed the presence of the w1 fragment in
the second isomer (tr 9.7 min) but not in the first isomer
(tr 8.9 min). This could be explained by alkylation of the
w1 fragment which did not occur in the second isomer.
This also meant that there was a slight preference for
alkylation of the G at the 5-end in d(GG). However, no
positive proof was found concerning the 3-terminal
fragment ion carrying the modification.
Analyzing the data from the alkylated d(GA)
showed an alkylation ratio of 1:15 (Isomer 1/Isomer 2).
MS/MS data from the first isomer (tr 8.0 min) with [M
 H]  847 showed the presence of a product-ion at
Figure 7. Chromatographic separation of the reaction mixture of
the melphalan alkylated hepta-mers d(GTTTTTT), d(TTTGTTT),
and d(TTTTTTG) on a reversed phase analytical column (C18, 300
m i.d., 5 cm length). Mobile phases consisted of A: 400 mM HFiP
in H2O (pH 7); B: 400 mM HFiP in MeOH (pH 7). The starting
conditions of the mobile phase were 98% A, 2% B. These were
maintained for 2 min. Then a linear gradient was started reaching
20% A, 80% B in 18 min. These conditions were maintained for 10
min. One signal can be seen which represents alkylation on the
guanine residue. Low energy CAD product ion spectra were
performed on the [M  4H]4ions.m/z 402 which could be explained by the alkylation of
the adenine base residue. Analogously in the MS/MS
spectra of the second isomer (tr 9.4 min) an alkylated
guanine residue could be found at m/z 418. A study of
the melphalan alkylated d(GC) showed an even lesser
amount of alkylation on the cytosine moiety compared
with the neighboring guanine moiety. An alkylation
ratio of 1:26 could be observed. The low energy CAD
product ion spectra of the monoalkylated isomer 1 of
d(GC) (tr 7.4 min) with [M  H]
  823 resulted in the
formation of an ion at m/z 418, which represents an
alkylated guanine residue. Isomer 2 (tr 8.2 min) repre-
sented the d(GC) with alkylation position at the cyto-
sine moiety. This was proven by the occurrence of a
product-ion at m/z 378 which corresponded to an alky-
lated cytidine residue.
Data from the monoalkylated d(GT) showed, as
expected, only one isomer at the corresponding m/z of
837. Alkylation could only be observed at the guanine
moiety. In general one can conclude that melphalan
alkylation specificity is in the order of G A C ( T).
This corresponds to earlier published reports [2, 5].
Melphalan Alkylation of the 2-
Oligodeoxynucleotides 4-mers
Reaction mixtures became somewhat more complicated
when alkylating a 4-mer such as d(AGCT) as shown in
Figure 5. In this case there were three major alkylation
positions: At the C- , A-, and G-base. In the correspond-
ing chromatogram one could indeed see three isomers
with a m/z of 720 ([M  H]2). In Figure 5 the low
energy CAD product ion spectra are also shown for the
three different isomers. The first isomer (tr  13.24 min)
showed product ions which corresponded to w1-, w2-,
and w3-fragments. This could only be explained by
alkylation of the adenine moiety. The second isomer (tr
 14.06 min) had a different fragmentation behavior
under low energy CAD conditions; only w1-fragments
were observed. Another major fragment was the a3-B3-
fragment indicating that melphalan was positioned at
the cytosine base. This assumption was supported by
the presence of a product-ion at m/z 878 corresponding
to a [w2  mel]
-fragment. The third and major isomer
(tr  15.00 min) showed product ions at m/z 321 and 610
which were assigned to the w1- and w2-fragments. A
major product ion was present at m/z 418 which was
explained by a melphalan alkylated guanine base.
These data showed that alkylation can occur at any
position in an oligodeoxynucleotide chain. The w-ion
series showed a good reproducibility to determine a
modification site in melphalan treated 2-ODNs. In
spite of the bifunctional alkylation character of melpha-
lan no cross link adducts could be observed. This is in
accordance with our earlier published results in which
it was stated that melphalan cross linking is not a
straightforward process [5]. Also, no bis-alkylated 2-
ODNs were detected.
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could be observed with respective retention times of
12.95 min and 16.62 min. (Figure 6). The first isomer
([M  2H]2  720.5) gave product ions corresponding
to w1- and w2-fragments. The w3-fragment was not
present but instead a [d1-H2Omel]
-fragment (m/z
597) was observed. Moreover, a product ion with m/z
Figure 8. Chromatographic separation of the r
d(CGTGAGCG) on a reversed phase analytical c
consisted of A: 400 mM HFiP in H2O (pH 7); B: 40
of the mobile phase were 98% A, 2% B. These w
started reaching 20% A, 80% B in 18 min. These c
be seen which represents alkylation on the G4-gu
in the areas which show the important product418 was present which corresponded to an alkylated
guanine base. Therefore, it was concluded that melpha-
lan was located at the 5-endstanding guanine base. In
the product ion spectrum of the second isomer, only the
w1-ion from the w-series could be observed. Next to this
the a3-B3- and the d2-ions were very abundant. This,
and with a product ion at m/z 418 (alkylated guanine)
n mixture of the melphalan alkylated octa-mer
n (C18, 300 m i.d., 5 cm length). Mobile phases
HFiP in MeOH (pH 7); The starting conditions
aintained for 2 min. Then a linear gradient was
ions were maintained for 10 min. One signal can
e residue. The product-ion spectrum is enlarged
w3 and w42 as discussed in the text.eactio
olum
0 mM
ere m
ondit
anin
-ions
578 VAN DEN DRIESSCHE ET AL. J Am Soc Mass Spectrom 2004, 15, 568–579taken into account, a modification on the guanine
moiety at the 3-position was proposed.
A difference in alkylation preference for both G-
residues could be observed when studying the alky-
lated d(GCGC). There seemed to be a slight preference
for alkylation on the guanine base at the 3-position.
When alkylating d(GGGG), only one isomer was found
which corresponded to an alkylation at the 5-position.
This was proven by the presence of w1-, w2-, as well as
w3-fragments, in combination with the alkylated a2-B2-
fragment ([a2-B2  mel]
). The difference with the
d(GCGC) alkylation study might be explained by the
more steric hindered position if G is located between
two purines instead of two pyrimidines.
Melphalan Alkylation of the 2-
Oligodeoxynucleotides Hepta-mers
When studying the low energy product ion spectra of
larger 2-oligodeoxynucleotides it was not always pos-
sible to observe the whole series of w-, d-, a-B-, and
y-fragments. In addition, product ion spectra had to be
taken of the adducted 2-ODNs, which were present in
very low amounts if compared with the amount of
unmodified species. Since product ions were already
very low abundant in the low energy CAD spectra of
the unmodified 2-ODNs, it was also very difficult to
detect them in the product ion spectra of the modified
ones. From Table 1 the conclusion could be made that
for the hepta-mers almost the whole w-series could be
observed (singly and/or doubly charged). Also the y-
and the a-B-series were almost complete. Only the
d-series was limited in the higher mass range (900
a.m.u.). However, an important remark has to be made.
The identity of certain series of fragment ions is a
general problem when analyzing symmetric sequences,
since they generate isobaric 5- and 3-fragment ions.
This can also be seen in Table 1. Since we cannot
distinguish between these two isobaric series, the w-ion
series observed for d(TTTGTTT) can also be the d-ion
series. When we take a general look at the characteris-
tics of the product ion spectra of the melphalan reacted
hepta-mers d(GTTTTTT), d(TTTGTTT), and
d(TTTTTTG) (Figure 7), a great resemblance could be
observed. In the case of d(GTTTTTT) we expected
adduct formation on the guanine base only. In the
chromatogram only one peak could be detected with a
tr  12.31 min. Low energy CAD product ion spectra of
[M  4H]4  589.2 showed an identical w-series
compared to the corresponding unmodified 2-ODN.
The d1- and d2-ions were replaced by [d1  mel]
- and
[d2  mel]
-ions, and could only be observed by
enlarging the spectra due to their low abundances.
Nevertheless, the data proved alkylation at the 5-
endstanding guanine base. If the modified d(TTTGTTT)
was fragmented one could see in the lower mass range
the w- and d-ions also observed in the unmodified
2-ODN. Next to this a product ion at m/z 418 waspresent assigned to an alkylated guanine residue. In
this case no fragments were present in the higher mass
region (800 a.m.u.), despite the use of very low
collision energies (15 eV). Fragmenting the melpha-
lan-modified d(TTTTTTG) only the d-ions were identi-
cal to the unmodified 2-ODN. The w1- and w2-ions
were detected as [w1  mel]
- and [w2  mel]
-ions.
This proved that melphalan alkylation occured at the
3-end of the sequence. However, these results only
proof that our LC-ES MS/MS method is useful in the
field of DNA adduct analysis of dODNs. Alkylation
sites in the middle as well as at the end of an oligonu-
cleotide chain could be detected.
Melphalan Alkylation of the d(CGTGAGCG)
Octamer
For the adducted octa-mer d(CGTGAGCG) (Figure 8)
only one compound was observed with the highest
abundance at [M  4H]4  678.7. A major product ion
of this compound was detected at m/z 418 correspond-
ing to a melphalan alkylated guanine residue. Since
four guanine bases were present in this 2-ODN, four
possible G-modification sites were available. Compari-
son of the low energy product ion spectrum of the
unmodified and modified d(CGTGAGCG) showed that
w1-, w2-, w3-, and the doubly charged w4-ions were
present in both cases. This meant that the modification
was not present in the last four bases A, G, C, and G. In
addition there was a major product ion at m/z 1019
which corresponded to the a4-B4-fragment. Therefore,
alkylation at the first three bases was excluded. The
abundance of this fragment was relatively pronounced
compared to the same product ion from the unmodified
2-ODN. This indicated adduct formation on G4 fol-
lowed by a facilitated depurination, already observed in
earlier studies [4, 5, 24].
Conclusion
If di-mers or tetra-mers of 2-ODNs were reacted with
melphalan, alkylation could occur at different positions
in the chain. In most cases we were able to separate the
isomers of the small modified 2-ODNs. Undertaking
this study, additional information on the melphalan
alkylation specificity was gathered. For this reason, this
study is complementary to our earlier performed in
vitro and in vivo studies. By choosing a specific oli-
godeoxynucleotide sequence a difference in alkylation
specificity was seen: Interpreting the ES-MS and ES-
MS/MS data of alkylated d(GG), d(GA), d(GC), and
d(GT) one could notice that two isomers were formed in
d(GG), d(GA), and d(GC). In general one can conclude
that melphalan alkylation specificity is in the order of G
 A  C ( T). When studying larger unmodified
and modified 2-ODNs, it was observed that melphalan
alkylation only occurred at specific positions in the
chain, more precisely at the guanine moiety. The study
579J Am Soc Mass Spectrom 2004, 15, 568–579 LC-ES MS/MS OF 2-OLIGODEOXYNUCLEOTIDESof the alkylation site in a melphalan treated octamer
revealed the presence of G alkylation.
In spite of the bifunctional alkylation character of
melphalan, no cross link adducts could be observed.
This is in accordance with earlier published results
stating that cross linking by melphalan is not a straight-
forward process [5]. Also, no bis-alkylated 2-ODNs
were detected.
Acknowledgments
The authors acknowledge the Foundation for Scientific Research
Flanders (FWO-Vlaanderen) for a grant. BVdD is especially in-
debted to the IWT for a grant. The authors also thank the
University of Antwerp and the Flemish government (GOA-action)
for financial support. They acknowledge Jef Schrooten for techni-
cal support.
References
1. Hemminki, K.; Koskinen, M.; Rajaniemi, H.; Zhao, C. DNA
Adducts, Mutations, and Cancer 2000. Reg. Toxicol. Pharmacol.
2000, 32, 264–275.
2. Furner, R. L.; Brown, R. K. L-Phenylalanine Mustard (L-
Pam)—the First 25 Years. Cancer Treat. Rep. 1980, 64, 559–574.
3. Mattes, W. B.; Hartley, J. A.; Kohn, K. W. DNA Sequence
Selectivity of Guanine-N7 Alkylation by Nitrogen Mustards.
Nucleic Acids Res. 1986, 14, 2971–2987.
4. Hoes, I.; Lemiere, F.; Van Dongen, W.; Vanhoutte, K.; Esmans,
E. L.; Van Bockstaele, D.; Berneman, Z.; Deforce, D.; Van den
Eckhout, E. G. Analysis of Melphalan Adducts of 2-De-
oxynucleotides in Calf Thymus DNA Hydrolysates by Capil-
lary High Performance Liquid Chromatography-Electrospray
Tandem Mass Spectrometry. J. Chromatogr. B Biomed. Sci. Appl.
1999, 736, 43–59.
5. Van den Driessche, B.; Lemie`re, F.; Van Dongen, W.; Esmans,
E. L. Alkylation of DNA by Melphalan: Investigation of
Capillary Liquid Chromatography-Electrospray Ionization
Tandem Mass Spectrometry in the Study of the Adducts at the
Nucleoside Level. J. Chromatogr. B Anal. Technol. Biomed. Life
Sci. 2003, 785, 21–37.
6. Esmans, E. L.; Broes, D.; Hoes, I.; Lemie`re, F.; Vanhoutte, K.
Liquid Chromatography-Mass Spectrometry in Nucleoside,
Nucleotide, and Modified Nucleotide Characterization.
J. Chromatogr. A. 1998, 794, 109–127.
7. Brown, K.; Harvey, C. A.; Turteltaub, K. W.; Shields, S. J.
Structural Characterization of Carcinogen-Modified Oligode-
oxynucleotide Adducts Using Matrix-Assisted Laser Desorp-
tion/Ionization Mass Spectrometry. J. Mass Spectrom. 2003, 38,
68–79.
8. Kirpekar, F.; Nordhoff, E.; Larsen, L. K.; Kristiansen, K.;
Roepstorff, P.; Hillenkamp, F. DNA Sequence Analysis by
MALDI Mass Spectrometry. Nucleic Acids Res. 1998, 26, 2554–
2559.
9. Glover, R. P.; Sweetman, G. M.; Farmer, P. B.; Roberts, G. C.
Sequencing of Oligonucleotides Using High Performance Liq-
uid Chromatography and Electrospray Mass Spectrometry.
Rapid Commun. Mass Spectrom. 1995, 9, 897–901.10. Covey, T. R.; Bonner, R. F.; Shushan, B. I.; Henion, J. The
Determination of Protein, Oligonucleotide, and Peptide Mo-
lecular Weights by Ion-Spray Mass Spectrometry. Rapid Com-
mun. Mass Spectrom. 1988, 2, 249–256.
11. Potier, N.; Van Dorsselaer, A.; Cordier, Y.; Roch, O.; Bischoff,
R. Negative Electrospray Ionization Mass Spectrometry of
Synthetic and Chemically Modified Oligonucleotides. Nucleic
Acids Res. 1994, 22, 3895–3903.
12. McLuckey, S. A.; Wu, J.; Bundy, J. L.; Stephenson, J. L., Jr.;
Hurst, G. B. Oligonucleotide Mixture Analysis via Electros-
pray and Ion/Ion Reactions in a Quadrupole Ion Trap. Anal.
Chem 2002, 74, 976–984.
13. Wan, K. X.; Gross, M. L. Fragmentation Mechanisms of
Oligodeoxynucleotides: Effects of Replacing Phosphates with
Methylphosphonates and Thymines with Other Bases in T-
Rich Sequences. J. Am. Soc Mass Spectrom. 2001, 12, 580–589.
14. Wan, K. X.; Gross, J.; Hillenkamp, F.; Gross, M. L. Fragmen-
tation Mechanisms of Oligodeoxynucleotides Studied by H/D
Exchange and Electrospray Ionization Tandem Mass Spectro-
metry. J. Am. Soc Mass Spectrom. 2001, 12, 193–205.
15. Wang, Y.; Taylor, J. S.; Gross, M. L. Fragmentation of Photo-
modified Oligodeoxynucleotides Adducted with Metal Ions in
an Electrospray-Ionization Ion-Trap Mass Spectrometer. J. Am.
Soc Mass Spectrom. 2001, 12, 1174–1179.
16. Wang, Y.; Taylor, J. S.; Gross, M. L. Fragmentation of Electro-
spray-Produced Oligodeoxynucleotide Ions Adducted to
Metal Ions. J. Am. Soc Mass Spectrom. 2001, 12, 550–556.
17. Wang, Z.; Wan, K. X.; Ramanathan, R.; Taylor, J. S.; Gross,
M. L. Structure and Fragmentation Mechanisms of Isomeric
T-Rich Oligodeoxynucleotides: A Comparison of Four Tan-
dem Mass Spectrometric Methods. J. Am. Soc Mass Spectrom.
1998, 9, 683–691.
18. Ni, J.; Pomerantz, C.; Rozenski, J.; Zhang, Y.; McCloskey, J. A.
Interpretation of Oligonucleotide Mass Spectra for Determina-
tion of Sequence Using Electrospray Ionization and Tandem
Mass Spectrometry. Anal. Chem 1996, 68, 1989–1999.
19. Rozenski, J.; McCloskey, J. A. Determination of Nearest
Neighbors in Nucleic Acids by Mass Spectrometry. Anal. Chem
1999, 71, 1454–1459.
20. Apffel, A.; Chakel, J. A.; Fischer, S.; Lichtenwalter, K.; Han-
cock, W. S. New Procedure for the Use of High Performance
Liquid Chromatography Electrospray Ionization Mass Spec-
trometry for the Analysis of Nucleotides and Ooligonucleoti-
des. J. Chromatogr. A 1997, 777, 3–21.
21. Apffel, A.; Chakel, J. A.; Fischer, S.; Lichtenwalter, K.; Han-
cock, W. S. Analysis of Oligonucleotides by HPLC-Electros-
pray Ionization Mass Spectrometry. Anal. Chem. 1997, 69,
1320–1325.
22. Boschenok, J.; Sheil, M. M. Electrospray Tandem Mass Spec-
trometry of Nucleotides. Rapid Commun. Mass Spectrom. 1996,
10, 144–149.
23. McLuckey, S. A.; Glish, G. L.; Van Berkel, G. J. Charge
Determination of Product Ions Formed from Collision-In-
duced Dissociation of Multiply Protonated Molecules via
Ion/Molecule Reactions. Anal. Chem 1991, 63, 1971–1978.
24. Hoes, I.; Van Dongen, W.; Lemiere, F.; Esmans, E. L.; Van
Bockstaele, D.; Berneman, Z. N. Comparison Between Capil-
lary and Nano Liquid Chromatography-Electrospray Mass
Spectrometry for the Analysis of Minor DNA Melphalan
Adducts. J. Chromatogr. B Biomed. Sci. Appl. 2000, 748, 197–212.
